ATE277907T1 - Blutzuckersenkende und lipidsenkende verbindungen - Google Patents

Blutzuckersenkende und lipidsenkende verbindungen

Info

Publication number
ATE277907T1
ATE277907T1 AT97931523T AT97931523T ATE277907T1 AT E277907 T1 ATE277907 T1 AT E277907T1 AT 97931523 T AT97931523 T AT 97931523T AT 97931523 T AT97931523 T AT 97931523T AT E277907 T1 ATE277907 T1 AT E277907T1
Authority
AT
Austria
Prior art keywords
lowering
compounds
blood sugar
lipid
lipid lowering
Prior art date
Application number
AT97931523T
Other languages
English (en)
Inventor
Samuel J Dominianni
William H Gritton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE277907T1 publication Critical patent/ATE277907T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97931523T 1996-07-01 1997-06-30 Blutzuckersenkende und lipidsenkende verbindungen ATE277907T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2101796P 1996-07-01 1996-07-01
PCT/US1997/011514 WO1998000403A1 (en) 1996-07-01 1997-06-30 Hypoglycemic and hypolipidemic compounds

Publications (1)

Publication Number Publication Date
ATE277907T1 true ATE277907T1 (de) 2004-10-15

Family

ID=21801860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97931523T ATE277907T1 (de) 1996-07-01 1997-06-30 Blutzuckersenkende und lipidsenkende verbindungen

Country Status (10)

Country Link
US (1) US6121282A (de)
EP (1) EP1019378B1 (de)
JP (1) JP2000515501A (de)
AT (1) ATE277907T1 (de)
AU (1) AU3513497A (de)
CA (1) CA2259431A1 (de)
DE (1) DE69731003D1 (de)
IL (1) IL121203A (de)
WO (1) WO1998000403A1 (de)
ZA (1) ZA975867B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI302149B (en) 1999-09-22 2008-10-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
US6414002B1 (en) 1999-09-22 2002-07-02 Bristol-Myers Squibb Company Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
PL356769A1 (en) * 1999-12-03 2004-07-12 Kyoto Pharmaceutical Industries, Ltd. Novel heterocyclic compounds and salts thereof and medicinal use of the same
US7187947B1 (en) 2000-03-28 2007-03-06 Affinity Labs, Llc System and method for communicating selected information to an electronic device
YU94203A (sh) 2001-05-29 2006-08-17 Kyoto Pharmaceutical Industries Ltd. Novi heterociklični derivati i njihova upotreba u medicini
CN1242994C (zh) 2001-05-29 2006-02-22 京都药品工业株式会社 杂环化合物及其医疗用途
JPWO2002102780A1 (ja) * 2001-06-18 2004-09-30 小野薬品工業株式会社 テトラヒドロキノリン誘導体化合物およびその化合物を有効成分として含有する薬剤
CA2463922C (en) 2001-06-27 2013-07-16 4 Media, Inc. Improved media delivery platform
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
PL374860A1 (en) 2002-07-09 2005-11-14 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
CA2527691C (en) * 2003-05-30 2013-01-22 Takeda Pharmaceutical Company Limited Condensed ring compound
JP2007520543A (ja) 2004-02-04 2007-07-26 ファイザー・プロダクツ・インク 置換キノリン化合物
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
WO2012033195A1 (ja) * 2010-09-10 2012-03-15 京都薬品工業株式会社 複素環化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988720A (en) * 1985-05-28 1991-01-29 Beecham Group P.L.C. Novel treatment of hyperglycaemia
US4999363A (en) * 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU6368090A (en) * 1989-10-03 1991-04-11 Warner-Lambert Company Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
EP0543018B1 (de) * 1991-06-07 1996-01-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetikum
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
JP2759228B2 (ja) * 1992-05-21 1998-05-28 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US5236934A (en) * 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
GB9311661D0 (en) * 1993-06-05 1993-07-21 Smithkline Beecham Plc Novel compounds
US5591862A (en) * 1993-06-11 1997-01-07 Takeda Chemical Industries, Ltd. Tetrazole derivatives, their production and use
AU678625B2 (en) * 1993-09-30 1997-06-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
US5616819A (en) * 1995-08-28 1997-04-01 Laroche Industries Inc. Process for preparing fluorinated aliphatic compounds
US5885327A (en) * 1995-09-12 1999-03-23 Henkel Corporation Process for the recovery of gold
DE19535243A1 (de) * 1995-09-22 1997-03-27 Bayer Ag Neue Zwischenprodukte für die Synthese von Bisphosphinverbindungen

Also Published As

Publication number Publication date
IL121203A (en) 2001-04-30
EP1019378B1 (de) 2004-09-29
EP1019378A4 (de) 2001-09-26
US6121282A (en) 2000-09-19
JP2000515501A (ja) 2000-11-21
DE69731003D1 (de) 2004-11-04
WO1998000403A1 (en) 1998-01-08
EP1019378A1 (de) 2000-07-19
IL121203A0 (en) 1997-11-20
CA2259431A1 (en) 1998-01-08
AU3513497A (en) 1998-01-21
ZA975867B (en) 1999-01-04

Similar Documents

Publication Publication Date Title
ATE277907T1 (de) Blutzuckersenkende und lipidsenkende verbindungen
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
HUP9800523A2 (hu) Inzulinszármazékok
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK233586D0 (da) 5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
RU94022479A (ru) Применение антиэстрогенных соединений, а также фармацевтически приемлемых солей и сольватов для уменьшения концентрации глюкозы в крови, фармацевтический препарат
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE102604T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
RU1833372C (ru) Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK88087A (da) Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem
ES2171233T3 (es) Uso de eliprodil para la preparacion de un medicamento para el tratamiento de trastornos isquemicos de la retina o el nervio optico.
DE69626544T2 (de) Arzneistoffe
ES2043719T3 (es) Administracion de farmacos por via percutanea.
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
SE9000207L (sv) Laekemedel samt anvaendningen av detsamma
CY1105463T1 (el) Ελεγχομενη χορηγηση αντικαταθλιπτικων
FR2716193B1 (fr) Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties